Active specific immunization in the treatment of patients with melanoma

Seminars in Oncology

Volumn 23, Issue 6, 1996, Pages 773-781

  Mastrangelo, M J ^a   Maguire H C , Jr ^a   Sato, T ^a   Nathan, F E ^a   Berd, D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYCLOPHOSPHAMIDE; DACARBAZINE; SEMUSTINE; TUMOR ANTIGEN; TUMOR VACCINE; VINCRISTINE;

CANCER IMMUNIZATION; CANCER SURVIVAL; CLINICAL TRIAL; GENETIC ENGINEERING; HUMAN; IMMUNE RESPONSE; IMMUNOPOTENTIATION; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; REVIEW; TUMOR REGRESSION;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, NEOPLASM; BCG VACCINE; CANCER VACCINES; CYCLOPHOSPHAMIDE; HUMANS; MELANOMA; NEOPLASM PROTEINS; REMISSION INDUCTION; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, CONJUGATE; VACCINES, SYNTHETIC;

EID: 0030460321     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)